Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials

Vascular Medicine

Volumn 10, Issue 3, 2005, Pages 207-213

  Hiatt, William R ^a,b   Cox, Lisa ^a   Greenwalt, Marilyn ^a   Griffin, Ali ^a   Schechter, Cynthia ^a  

^a University of Colorado Health Sciences Center ^*  (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Clinical trials; Peripheral arterial disease; Peripheral vascular disease; Quality assurance; Questionnaires; Treadmill testing

Indexed keywords

NEW DRUG; OXYGEN; PERIPHERAL VASODILATING AGENT;

ANKLE BRACHIAL INDEX; ARTICLE; CLAUDICATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EQUIPMENT; HEMODYNAMIC MONITORING; HUMAN; LEG ISCHEMIA; MEASUREMENT; OUTCOMES RESEARCH; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; STAFF TRAINING; TIME; TRANSCUTANEOUS OXYGEN MONITORING; TREADMILL EXERCISE; WALKING;

BLOOD GAS MONITORING, TRANSCUTANEOUS; BLOOD PRESSURE DETERMINATION; CLINICAL TRIALS; EXERCISE TEST; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES;

EID: 26944475972     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x05vm628oa     Document Type: Article

References (8)

1. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608-21.
2. Nehler MR, Hiatt WR. Exercise therapy for claudication. Ann Vasc Surg 1999; 13: 109-14.
3. Labs KH, Dormandy JA, Jaeger KA, Stuerzebecher C, Hiatt WR. Trans-atlantic conference on clinical trial guidelines in PAOD (peripheral arterial occlusive disease) clinical trial methodology. Eur J Vasc Endovasc Surg 1999; 18: 253-65.
4. Hiatt WR, Hirsch AT, Cooke JP, Olin JW, Brater DC, Creager MA. Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy. Vasc Med 2004; 9: 18-25.
5. Mohler ER, III, Hiatt WR, Olin JW, Wade M, Jeffs R, Hirsch AT. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial. J Am Coll Cardiol 2003; 41: 1679-86.
6. Rajagopalan S, Mohler ER, III, Lederman RJ et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003; 108: 1933-38.
7. Hiatt WR, Regensteiner JG, Creager MA et al. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med 2001; 110: 616-22.
8. Melillo E, Catapano G, Ferrari M, Pedrinelli R. Transcutaneous oxygen tension measurement in patients with chronic arterial obstructive disease: reliability and long-term variability of the method. Angiology 1994; 45: 469-75.